“Comparative Effectiveness and Safety of High-Intensity Statins (Atorvastatin Vs Rosuvastatin) in Coronary Heart Disease Patients After Percutaneous Coronary Intervention (PCI) : A Literature Review”. Journal of Pharmaceutical and Sciences, vol. 9, no. 3, Aug. 2026, pp. 2815-26, https://doi.org/10.36490/journal-jps.com.v9i3.1676.